Investment Q&A

Q: Hi there,

Can I please get your opinion on Payfare? Would you rate this a buy or sell and if a buy, at what price do you see as an entry point? If there are a red flag that would prevent you from adding it to your Growth Model Portfolio, what would that be?

Thank you!

Q: Hello 5i, Could you comment on NUG as they have suspended there exploration are they a high spec stock or are they dead in the water.

Q: Hi Team,
Having not researched this name myself yet, what is the story behind HPS? It's an old company and looking at a 10yr chart had been flat for years between $5-$10 range. Now since 2021 it went parabolic to $84 today. What changed in its business to justify such a drastic gain? Perhaps I am a bit cynical or cautious; but I am a bit hesitant being told in the past not to invest in names that have gone parabolic so quickly? At least without a significant pullback. Thanks for your insight!

Shane

Q: I recently stumbled on this company and gambled on a small purchase. It doesn't trade much which I dislike but there are other things that I do like (stock options instead of salary expense/R&D financed by large partners/green product/innovative etc.). What are your thoughts?

Q: Overall, I prefer small and mid-cap Canadian stocks for growth and accept the risk that goes with this. Currently, I do not have anything in the tech space and would appreciate if you would suggest a few names.

Thank you,
John

Q: With respect to a potential take-over in a family run company, does his have a coattail provision.

Thanks

Q: In an answer in November you seemed somewhat optimistic on the outlook for AND . But in a previous answer in July you referred to it as " not needed to be owned " .... How do you feel about in now in the new year and why ? Thanks Garth

Q: your view on vhi 1-2 years
thank you

Q: hi, would you consider these more on the risky side, or just smaller cap? I read Hammond EPS around 15 which seems fine to me. I can't find an EPS on LMN?
is this a decent entry point for each? if not, what price would be a more reasonable entry point?
cheers, Chris

Q: May I have your latest thoughts on QS? Do think the latest test results from Volkswagen to be positive? Do you expect QS will need to raise more capital by issuing more shares? I’m curious why the stock is listed on the NYSE instead of the NASDAQ. Are the listing costs similar?
Thanks,
Jim

Q: your opinion on vnp please.
thank you.

Q: after the recent reverse split and additional financing, how many total shares are now outstanding and what % owned by insiders if available. Thanks

Q: Are there niche radio station companies out there worth pursuing? CJR.b:CA is an apparent "turkey" in Canada but does SGA:US merit some further research? Are there others?

Q: What is your opinion of Faraco?
Thanks

Q: I have owned Theratechnologies since 2018 and watched this stock fall since I purchased it. The stock has been rising the last few weeks and was up 23% on Friday. I couldn't find any exciting press releases that would explain the increase. Do you know of any reason for the recent increase?

The 5 analysts listed on Qtrade have a price target of anywhere from $5.50-$12.04. How much faith can we put in the price targets of analysts?

I was quite excited that it was up to $3.03 but just noticed there was a 4 for 1 stock split in August 2023 so my 700 shares are now only 175 shares. So rather than being down 60% I am actually down 90%. Yikes, I better not tell my wife about this trade!

My holdings in TH are only worth $530 now. Should I sell this loser now or is it worth waiting until the annual report (November year end) comes out?

Q: Can you recommend any small or medium cap, US dollar denominated ETFs, that don’t have any dividends, phantom dividends, ROC, etc? Only looking for a capital gain/loss.

Q: I have small positions in TOI, NVEI, SIS, TOY and WELL in a TFSA, and am considering
adding to one of these.
Please rate these stocks in terms of growth prospects and indicate how much patience might be required.
Thanks.

Q: Hello,
Happy New Year; is Electrovaya worth stepping into or is it still too risky? Knight seems to have perked up a bit. Is the launch of the drug causing the small surge and is it something noteworthy or will this be another slow rise and than fall back to the 5 dollar level? Much appreciated.

Q: Hi - what is the upside potential for this laggard and what are the catalysts if any

Q: Hi There,

Which 2-3 Canadian companies would you be adding to with your TFSA contribution this year?

Thanks